Masking of Fibrinolytic Response to Stimulation by an Inhibitor of Tissue-Type Plasminogen Activator in Plasma

Summary

Patients with hyperlipoproteinaemia or spontaneous thromboembolism, known to be poor responders to DDAVP or to venous occlusion with regard to the rise in fibrinolytic activity of the blood, appeared to show a normal increase in t-PA-antigen after the same procedure. In their plasma a higher than normal level of free, fast-acting t-PA-inhibitor was found as measured by titration with purified t-PA. This free t-PA-inhibitor level only decreased after the test, in contrast to its complete disappearance in normal responders. The same happened in a healthy volunteer who failed to exhibit a rise in fibrinolytic activity after exhaustive exercise.

We suppose that the lack of response of the fibrinolytic activity in these cases is due to a high inhibitor level and not to impaired release of t-PA into the blood.

In contrast, patients with terminal renal insufficiency showed only a slight increase in t-PA-antigen after DDAVP. The level of free fast-acting inhibitor was normal in most cases and did not change appreciably during DDAVP-infusion. In these patients, a true impairment of the release of t-PA appears to exist.

Keywords

t-PA-inhibitor - Standard - DDAVP - Exercise - Venous occlusion

• References

• 1 Nilsson IM, Pandolfi M, Robertson B. Properties of fibrinolytic activators appearing after venous stasis and intravenous injection of nicotinic acid. Coagulation 1970; 3: 13-21
• 2 Kluft C. Studies on the fibrinolytic system in human plasma: Quantitative determination of plasminogen activators and proactivators. Thromb Haemostas 1979; 41: 365-383
• 3 Rijken DC, Wijngaards G, Welbergen J. Relationship between uterine tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res 1980; 18: 815-830
• 4 Brommer EJ P, Barrett-Bergshoeff MM, Allen RA, Schicht I, Bertina RM, Schalekamp MA D H. The use of desmopressin acetate (DD AVP) as a test of the fibrinolytic capacity of patients - Analysis of responders and non-responders. Thromb Haemostas 1982; 48: 156-161
• 5 Wiman B, Mellbring G, Rånby M. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. Clin Chim Acta 1983; 127: 279-288
• 6 Rijken DC, Julian-Vague I, De CockF, Collen D. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. J Lab Clin Med 1983; 101: 274-284
• 7 Cash J. A new approach to studies of the fibrinolytic enzyme system in man. Am Heart J 1968; 75: 424-427
• 8 Isacson S, Nilsson IM. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313-319
• 9 Browse NL, Gray L, Jarrett PE M, Morland M. Blood and vein-wall fibrinolytic activity in health and vascular disease. Br Med J 1977; 1: 478-481
• 10 Johansson L, Hedner U, Nilsson IM. A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. Acta Med Scand 1978; 203: 477-480
• 11 Dreyer NA, Pizzo SV. Blood coagulation and idiopathic thromboembolism among fertile women. Contraception 1980; 22: 123-135
• 12 Sundqvist S-B, Hedner U, Kullenberg HK E, Bergentz S-E. Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis. Br Med J 1981; 283: 265-267
• 13 Jørgensen M, Mortensen JZ, Madsen AG, Thorsen S, Jacobsen B. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. Scand J Haematol 1982; 29: 217-223
• 14 Stead NW, Bauer KA, Kinney TR, Lewis JG, Campbell EE, Shifman MA, Rosenberg RD, Pizzo SV. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIH/von Willebrand’s factor. Am J Med 1983; 74: 33-39
• 15 Hamulyak K, Brommer EJ P, Devilee PP, Hemker HC. Activation of coagulation and fibrinolysis during maximal physical exercise. Int J Sport Med. (in press)
• 16 Loskutoff DJ, Edgington TS. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci 1977; 74: 3903-3907
• 17 Levin E, Loskutoff DJ. Comparative studies of the fibrinolytic activity of cultured vascular cells. Thromb Res 1979; 15: 869-878
• 18 Loskutoff DJ, Edgington TS. An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem 1981; 256: 4142-4145
• 19 Emeis JJ, van Hinsbergh VW M, Verheijen JH, Wijngaards G. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun 1983; 110: 392-398
• 20 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas. (in press)
• 21 Verheijen JH, Rijken DC, Brommer EJ P, Chang GT G. Measurement of tissue-type plasminogen activator activity, antigen and inhibition in plasma. In: Clinical Aspects of Fibrinolysis and Thrombolysis. Jespersen J, Kluft C. (Eds) South Jutland University Press; Esbjerg, Denmark: 1983. pp 121-131
• 22 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
• 23 Kruithof EK O, Ransijn A, Bachmann F. Inhibition of tissue plasminogen activator by human plasma. In: Progress in Fibrinolysis. Davidson JF, Bachmann F, Bouvier CA, Kruithof EK O. (Eds) Churchill Livingstone; Edinburgh: 1983. 6 365-369
• 24 Rijken DC, van Hinsbergh VW M, Sens EH C. Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res 1984; 33: 145-153
• 25 Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
• 26 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
• 27 Verheijen JH, Chang GT G, Mullaart E. Inhibition of extrinsic (tissue-type) plasminogen activator by human plasma: evidence for the occurrence of a fast-acting inhibitor. Thromb Haemostas 1983; 50: 294 (Abstr)
• 28 Brommer EJ P, Gevers LeuvenJ A, Barrett-Bergshoeff MM, Schouten JA. Response of fibrinolytic activity and coagulation factor VIII to stimulation with DDAVP in hyperlipoproteinaemia. J Lab Clin Med 100: 105-114